See more : Icosavax, Inc. (ICVX) Income Statement Analysis – Financial Results
Complete financial analysis of Apollo Medical Holdings, Inc. (AMEH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Apollo Medical Holdings, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Sunwave Communications Co.Ltd (002115.SZ) Income Statement Analysis – Financial Results
- Taiwan Mask Corporation (2338.TW) Income Statement Analysis – Financial Results
- CompoSecure, Inc. (CMPOW) Income Statement Analysis – Financial Results
- ProSiebenSat.1 Media SE (PBSFF) Income Statement Analysis – Financial Results
- Genor Biopharma Holdings Limited (6998.HK) Income Statement Analysis – Financial Results
Apollo Medical Holdings, Inc. (AMEH)
About Apollo Medical Holdings, Inc.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.14B | 773.92M | 370.25M | 560.62M | 519.91M | 356.36M | 57.43M | 44.05M | 32.99M | 10.48M | 7.78M | 5.11M | 3.90M | 2.44M | 1.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 944.69M | 596.14M | 348.54M | 467.81M | 361.13M | 273.45M | 48.74M | 34.00M | 22.07M | 9.08M | 6.32M | 4.13M | 3.31M | 1.81M | 1.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 199.48M | 177.77M | 21.71M | 92.81M | 158.78M | 82.90M | 8.69M | 10.05M | 10.92M | 1.41M | 1.46M | 978.41K | 581.86K | 627.51K | 11.25K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 17.43% | 22.97% | 5.86% | 16.56% | 30.54% | 23.26% | 15.14% | 22.81% | 33.11% | 13.43% | 18.77% | 19.14% | 14.93% | 25.70% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 77.67M | 62.08M | 15.59M | 41.48M | 43.35M | 26.25M | 18.58M | 16.96M | 11.28M | 5.29M | 3.52M | 1.38M | 566.65K | 694.32K | 827.29K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 77.67M | 62.08M | 15.59M | 41.48M | 43.35M | 26.25M | 18.58M | 16.96M | 11.28M | 5.29M | 3.52M | 1.38M | 566.65K | 694.32K | 827.29K | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Other Expenses | 3.94M | -3.75M | 7.69M | 3.03M | 1.62M | 168.10K | 14.70K | 239.06K | 3.03K | 49.70K | -37.25K | 2.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 95.21M | 79.59M | 15.62M | 58.40M | 66.55M | 45.32M | 19.23M | 17.31M | 11.62M | 5.32M | 3.54M | 1.39M | 577.85K | 730.02K | 847.07K | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Cost & Expenses | 1.04B | 675.74M | 364.16M | 526.20M | 427.68M | 318.78M | 67.96M | 51.31M | 33.68M | 14.39M | 9.85M | 5.52M | 3.89M | 2.54M | 1.89M | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Interest Income | 1.98M | 1.57M | 405.00K | 2.02M | 1.26M | 1.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 7.92M | 5.39M | 2.53M | 4.73M | 561.00K | 79.69K | 82.91K | 542.30K | 1.33M | 679.18K | 930.18K | 304.03K | 126.43K | 53.13K | 55.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 29.09M | 11.03M | 25.93M | 18.43M | 19.30M | 19.08M | 351.40K | 351.40K | 334.43K | 31.36K | 20.92K | 12.59K | 11.20K | 35.70K | 19.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 133.35M | 111.40M | 40.27M | 50.85M | 106.29M | 56.72M | -9.88M | -6.68M | -356.87K | -3.83M | -2.09M | -397.90K | 15.21K | -66.81K | -816.04K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| EBITDA Ratio | 11.65% | 14.39% | 10.88% | 9.07% | 20.44% | 15.92% | -17.20% | -15.16% | -1.08% | -36.52% | -26.94% | -7.79% | 0.39% | -2.74% | -77.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 104.27M | 98.18M | 6.09M | 32.42M | 88.43M | 35.15M | -10.54M | -7.27M | -694.33K | -3.91M | -2.08M | -413.34K | 4.02K | -102.52K | -835.82K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| Operating Income Ratio | 9.11% | 12.69% | 1.64% | 5.78% | 17.01% | 9.86% | -18.35% | -16.50% | -2.10% | -37.29% | -26.73% | -8.09% | 0.10% | -4.20% | -79.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -17.65M | -20.43M | 2.78M | -8.57M | -9.60M | 14.57M | 1.81M | -978.30K | -489.83K | -629.48K | -6.82M | -301.19K | -158.75K | -92.77K | -55.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 86.62M | 77.75M | 8.87M | 25.84M | 82.63M | 49.71M | -8.73M | -8.24M | -1.18M | -4.54M | -8.90M | -714.53K | -154.73K | -195.28K | -891.02K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 7.57% | 10.05% | 2.40% | 4.61% | 15.89% | 13.95% | -15.20% | -18.72% | -3.59% | -43.30% | -114.45% | -13.98% | -3.97% | -8.00% | -84.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 40.88M | 31.69M | 9.18M | 8.17M | 22.36M | 3.89M | -47.50K | -71.04K | 163.79K | 19.51K | 4.80K | 5.82K | 1.60K | 800.00 | 800.00 | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Net Income | 45.17M | 68.92M | -23.75M | 14.12M | 10.84M | 25.80M | -8.97M | -9.34M | -1.80M | -5.02M | -8.90M | -720.35K | -156.33K | -196.08K | -891.82K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| Net Income Ratio | 3.95% | 8.91% | -6.42% | 2.52% | 2.08% | 7.24% | -15.62% | -21.21% | -5.46% | -47.88% | -114.51% | -14.09% | -4.01% | -8.03% | -84.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 1.00 | 1.57 | -0.65 | 0.41 | 0.33 | 0.80 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.06 | -0.07 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
| EPS Diluted | 0.99 | 1.52 | -0.63 | 0.39 | 0.29 | 0.80 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.06 | -0.07 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
| Weighted Avg Shares Out | 44.97M | 43.83M | 36.53M | 34.71M | 32.89M | 32.30M | 6.03M | 5.88M | 4.86M | 4.70M | 3.48M | 2.93M | 2.75M | 2.65M | 2.40M | 299.70K | 17.51K | 17.51K | 17.51K | 17.51K |
| Weighted Avg Shares Out (Dil) | 45.60M | 43.83M | 37.45M | 36.40M | 37.91M | 32.30M | 6.03M | 5.88M | 4.86M | 4.70M | 3.48M | 2.93M | 2.75M | 2.65M | 2.40M | 299.70K | 17.51K | 17.51K | 17.51K | 17.51K |
Apollo Medical Holdings, Inc. (AMEH) Upgraded to Strong Buy: Here's Why
Apollo Medical Holdings, Inc. (AMEH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for May 11th
AMEH, PYCR, AWH, SAND and MCD have been added to the Zacks Rank #1 (Strong Buy) List on May 11, 2023.
Apollo Medical Holdings Inc. (AMEH) Q1 2023 Earnings Call Transcript
Apollo Medical Holdings Inc. (NASDAQ:AMEH ) Q1 2023 Earnings Conference Call May 8, 2023 5:30 PM ET Company Participants Carolyne Sohn - VP of IR Brandon Sim - Co-CEO Chan Basho - Chief Financial Officer Conference Call Participants Ryan Daniels...
ELV vs. AMEH: Which Stock Is the Better Value Option?
Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and Apollo Medical Holdings, Inc. (AMEH). But which of these two companies is the best option for those looking for undervalued stocks?
Apollo Medical Holdings, Inc. Schedules 2023 First Quarter Financial Results Release and Conference Call
ALHAMBRA, Calif. , April 26, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of...
Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conferences
ALHAMBRA, Calif. , March 6, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of...
Apollo Medical Holdings Inc. (AMEH) Q4 2022 Earnings Call Transcript
Apollo Medical Holdings Inc. (NASDAQ:AMEH ) Q4 2022 Results Conference Call February 24, 2023 8:30 AM ET Company Participants Carolyne Sohn - VP of IR Brandon Sim - Co-CEO Chan Basho - Chief Strategy Officer & Interim CFO Conference Call...
Apollo Medical Holdings, Inc. (AMEH) Lags Q4 Earnings Estimates
Apollo Medical Holdings, Inc. (AMEH) delivered earnings and revenue surprises of -77.78% and 11.27%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Apollo Medical Holdings, Inc. Schedules 2022 Fourth Quarter and Year-end Financial Results Release and Conference Call
ALHAMBRA, Calif. , Feb. 9, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of...
Analysts Initiate Coverage: 4 Stocks to Buy for Higher Return
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Dorian (LPG), Agilysys (AGYS), Kyndryl (KD) and Apollo Medical (AMEH).
Source: https://incomestatements.info
Category: Stock Reports